M Musset
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
M Musset
44 papers receiving 587 citations
Peers
Comparison fields: 5 of 84
- Oncology 332
- Pathology and Forensic Medicine 164
- Hematology 80
- Genetics 72
- Reproductive Medicine 38
Countries citing papers authored by M Musset
This map shows the geographic impact of M Musset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Musset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Musset more than expected).
Fields of papers citing papers by M Musset
This network shows the impact of papers produced by M Musset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Musset. The network helps show where M Musset may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M Musset, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 10 | |
| 2 | 1999 | 44 | |
| 3 | 1997 | 63 | |
| 4 | 1993 | 1 | |
| 5 | 1991 | 7 | |
| 6 | Clinical characterization of imuthiol. | 1986 | 11 |
| 7 | An original method for submacroscopic metastases visualization in cases of cancer minimal residual disease. | 1986 | 12 |
| 8 | A phase II trial of immunorestoration with zinc gluconate in immunodepressed cancer patients. | 1986 | 8 |
| 9 | A phase I trial of trans-1-diaminocyclohexane oxalato-platinum (l-OHP). | 1986 | 77 |
| 10 | 1986 | 16 | |
| 11 | 1980 | 15 | |
| 12 | Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine. | 1978 | 47 |
| 13 | [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)]. | 1978 | 2 |
| 14 | 1978 | 9 | |
| 15 | 1976 | 14 | |
| 16 | Immunothérapie active des leucémies aiguës et des lymphosarcomes leucémiques. Bilar de 10 ans-Etude de 200 cas | 1975 | 3 |
| 17 | [Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV]. | 1975 | 1 |
| 18 | [Active immunotherapy of acute leukemia and leukemic lymphosarcoma. Results of 10 years. Study of 200 cases]. | 1975 | 1 |
| 19 | [Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213]. | 1975 | 2 |
| 20 | 1974 | 89 |
About M Musset
M Musset is a scholar working on Oncology, Genetics, Pathology and Forensic Medicine, Immunology and Hematology, having authored 46 papers that have together received 629 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Immunotherapy and Immune Responses (4 papers), Acute Myeloid Leukemia Research (4 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Oncology (332 citations), Pathology and Forensic Medicine (164 citations), Hematology (80 citations), Genetics (72 citations) and Reproductive Medicine (38 citations). M Musset has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include J. L. Misset, G Mathé, L Schwarzenberg, C Jasmin, Patricia Ribaud, G Mathé, F. de Vassal, M. Hayat, P Pouillart and Misset Jl. Their work appears in journals such as European Journal of Cancer, Cancer Immunology Immunotherapy, Cancer Chemotherapy and Pharmacology, Recent results in cancer research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.